Correlation Between Biomea Fusion and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Biomea Fusion and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Neurobo Pharmaceuticals.
Diversification Opportunities for Biomea Fusion and Neurobo Pharmaceuticals
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biomea and Neurobo is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biomea Fusion and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Neurobo Pharmaceuticals. In addition to that, Biomea Fusion is 1.03 times more volatile than Neurobo Pharmaceuticals. It trades about -0.66 of its total potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of volatility. If you would invest 285.00 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (43.00) from holding Neurobo Pharmaceuticals or give up 15.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Biomea Fusion |
| Neurobo Pharmaceuticals |
Biomea Fusion and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Neurobo Pharmaceuticals
The main advantage of trading using opposite Biomea Fusion and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |